ATG5 and chronic rhinosinusitis: In previous studies, mir-335-5p has been found to inhibit the inflammatory response in chronic rhinosinusitis (Gu et al., 2020); and moreover mir-335-5p could alleviate the inflammatory response and airway fibrosis by modulating ATG5, resulting in relief of childhood asthma (Liang et al., 2022).